dc.contributor.author |
Gallwitz, Baptist |
|
dc.date.accessioned |
2015-10-14T12:53:12Z |
|
dc.date.available |
2015-10-14T12:53:12Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
1178-203X |
|
dc.identifier.uri |
http://hdl.handle.net/10900/65549 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Dove Medical Press Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.2147/TCRM.S67076 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Management of patients with type 2 diabetes and mild/moderate renal impairment: profile of linagliptin |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20150901145020_02048 |
|
utue.publikation.seiten |
799-805 |
de_DE |
utue.personen.roh |
Gallwitz, Baptist |
|
dcterms.isPartOf.ZSTitelID |
Therapeutics and Clinical Risk Management |
de_DE |
dcterms.isPartOf.ZS-Volume |
11 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |